论文部分内容阅读
东风药业(600750)主营抗生素原料药、粉针剂、胶囊剂、片剂、糖浆剂及外用洗涤剂等医药产品的生产和销售。该公司1997和1998年的业绩一般,今年上半年由于国内青霉素系列产品市场持续疲软,主导产品青霉素库存较大,资金周转困难。为了减少库存,盘活资金,公司自5月下旬起调整生产经营策略,主动进行限产,上半年的主营业务收入为4247万元,比去年同期下降了56.8％,主营业务利润为3498万元,同比增长426％。为什么净利润大于主营业务利润呢?主要原因是:去年9月份,公司全权经营的江中制药(集团)有限责任公司委托的片剂生产线及相关资产,公司享有该部分资产的收益权,同时,按照受托管净资产的1％的比例向委托方江中制(集团)有限责任公司支付管理费用。而上半年取得托管经营收入4088万元,成本为200万元,因此托
Dongfeng Pharmaceutical (600750) Main antibiotic bulk drugs, injection, capsules, tablets, syrups and topical detergents and other pharmaceutical products production and sales. The company's performance in 1997 and 1998 was normal. In the first half of this year, due to the continuous weakness of the domestic market of penicillin products and the large inventory of penicillin, which is the leading product, the cash flow was difficult. In order to reduce inventory and liquidate funds, the Company adjusted its production and operation strategies since late May and took the initiative to limit the production. In the first half of the year, its main business income was 42.47 million yuan, down 56.8% over the same period of last year, and its main business profit was 34.98 million yuan Yuan, an increase of 426%. Why is the net profit greater than the profit of main business? The main reason is: in September last year, the company solely controlled by the Pharmaceutical (Group) Co., Ltd. commissioned tablet production line and related assets, the company enjoyed the proceeds of the right to part of the assets, at the same time , In accordance with the entrusted net assets of 1% of the proportion to the client Jiangzhong system (Group) Co., Ltd. to pay management fees. In the first half of the year, the Company achieved custody business income of 40.88 million yuan and the cost of 2 million yuan